GRP
RCKT icon

Global Retirement Partners’s Rocket Pharmaceuticals RCKT Stock Holding History

Global Retirement Partners’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65 Buy
+19
New +$63 ﹤0.01% 4456
2025
Q4 		$67 Buy
+19
New +$65 ﹤0.01% 4163
2024
Q4 		$1.13K Buy
+90
New +$1.35K ﹤0.01% 3251
2024
Q1 		– Sell
-200
Closed -$5.7K – 3466
2023
Q4 		$5.7K Buy
+200
New +$4.41K ﹤0.01% 2272

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Global Retirement Partners's RCKT Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Rocket Pharmaceuticals (RCKT) in Q2 2026: 19 shares worth $65. The stake represents ﹤0.01% of the portfolio and ranks #4456 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in RCKT as recently as Q4 2025.

Global Retirement Partners first reported a position in RCKT in Q4 2023 and has held it in 4 quarters since. The position peaked at $5.7K in Q4 2023. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Global Retirement Partners held 19 shares of Rocket Pharmaceuticals worth $65 as of Q2 2026.
  • Rocket Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
  • Rocket Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #4456 holding.
  • Global Retirement Partners first reported a position in Rocket Pharmaceuticals in Q4 2023 and has held it in 4 quarters since.
  • Global Retirement Partners's Rocket Pharmaceuticals position peaked at $5.7K in Q4 2023.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.